Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Panaxia Labs Israel Ltd (PNAX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9,578.0 +1901.0    +24.76%
25/04 - Closed. Currency in ILS ( Disclaimer )
Type:  Equity
Market:  Israel
ISIN:  IL0011043630 
S/N:  1104363
  • Volume: 1,098
  • Bid/Ask: 9,055.0 / 9,795.0
  • Day's Range: 7,830.0 - 10,300.0
Panaxia Labs Israel Ltd 9,578.0 +1901.0 +24.76%

Panaxia Labs Israel Ltd Company Profile

 
Get an in-depth profile of Panaxia Labs Israel Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryProfessional & Commercial Services
SectorIndustrials
Employees

-

Equity Type

ORD

Panaxia Labs Israel Ltd provides pharmaceutical solutions for patients and physicians in Israel and internationally. It offers pharma-grade smokeless cannabis products, such as oral tablets, orodispersible tablets, sublingual tablets, oral oils, sublingual drops, solution for inhalation, pastilles, topicals, suppositories, and cannabis extracts in ethanol under the NAXIVA – PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus brands. The company was incorporated in 2005 and is based in Lod, Israel.

Contact Information

Address Bat Sheva 1
Lod, 7120101
Israel
Phone 972 7 2274 4144
Fax 972 7 2393 8786

Top Executives

Name Age Since Title
Dedi Segal 47 - Founder & CEO & Director
Asi Rotbert 48 - Chief Business Officer & Director
Markus Veit 65 2019 Scientific Advisor
David Meiri - - Scientific Advisor
Aaron Ciechanover 77 2019 Scientific Advisor
Michal Sapir 67 2022 Independent External Director
Rinat Gazit 55 - Independent Director
Deir Noa Leibovich - - Scientific Advisor
Moshe Reuveni 68 - Independent External Director
Michal Marom-Brikman 55 - Independent External Director
Tal Yaron Eldar 61 - Director
Michal Dadon-Yagil 54 - Independent External Director
Essie Rothbert 49 - Chairman
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PNAX Comments

Write your thoughts about Panaxia Labs Israel Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email